Four Marijuana Stocks Surpassing Investor Expectations

CORAL GABLES, FL / ACCESSWIRE / March 19, 2019 / The marijuana stock market has demonstrated in the first few months of 2019 that, despite its connection the nascent cannabis sector, it a sect of the market worth paying attention to. The cannabis industry has been extremely fortunate in the U.S. to see a massive amount of support across the nation. Having said that, a small portion of smaller states, in terms of their tenable marijuana market size, have yet to realize the economic opportunities presented by legalizing cannabis. Following the passing of the U.S. Farm Bill, the cannabis sector has ramped up production on industrial hemp because of its naturally-occurring cannabidiol, and the hope is that the cannabis sector continues to grow and evolve in the future. Nabis Holdings (INNPF) (NAB), Newstrike Brands Ltd (OTC PINK: NWKRF), CannTrust Holdings Inc (CTST) (TRST.TO), and CV Sciences Inc (CVSI) are 4 pot stocks that could test March highs.

Nabis Holdings (INNPF) (NAB) is a Canadian investment company focused on investing in high-quality cash flowing and strategic assets across multiple aspects of the cannabis sector primarily in the U.S. limited license states with a roadmap to expand globally.

Nabis Holdings (INNPF) (NAB) earlier this month announced that it has entered into a revised agreement, co-led by Canaccord Genuity Corp. and Eventus Capital Corp., to increase the size of its previously announced amended brokered private placement of debenture units to raise gross proceeds of up to C$35,000,000.

Per the details of the agreement, the Company has increased the Agents' option, exercisable at any time up until 48 hours prior to the Closing Date, to arrange for the sale of additional Debenture Units for additional aggregate gross proceeds to the Company of up to C$10,000,000. If the Over-Allotment Option is exercised in full, the aggregate gross proceeds of the Amended Offering will be C$45,000,000.

For More Information On Nabis Holdings, Click Here

Newstrike Brands Ltd (NWKRF) announced earlier this month that the Company has entered into a definitive arrangement agreement under which HEXO Corp will acquire all of Newstrike's issued and outstanding common shares in an all-share transaction valued at approximately $263 million. Under the terms of the Arrangement Agreement, Newstrike shareholders will receive 0.06332 of a HEXO common share in exchange for each Newstrike common share held.

Jay Wilgar, CEO of Newstrike, said, "this is the most compelling combination we see in the Canadian cannabis sector. Our strength in Ontario and English Canada clearly complements HEXO's strong position in Quebec and creates an industry leader. The combination will deliver meaningful synergies, a stronger financial position with increased flexibility, and will position the combined company to meet growing consumer demand on a national basis. I believe this transaction is beneficial to our shareholders, customers, and employees."

For More Information On Newstrike Brands Ltd, Click Here

CannTrust Holdings Inc (CTST) (TRST) yesterday announced that the Company has filed a short form base shelf prospectus with the securities commissions in each of the provinces of Canada, except Québec, and a corresponding shelf registration statement on Form F-10 with the U.S. Securities and Exchange Commission under the U.S./Canada Multijurisdictional Disclosure System.

Per the details of the announcement, the shelf prospectus will allow the Company to offer up to C$700,000,000 of debt securities, warrants, subscription receipts, units or common shares, or any combination thereof, from time to time during the 25-month period that the Shelf Prospectus is effective.

For More Information On CannTrust Holdings Inc, Click Here

CV Sciences Inc (CVSI) last week announced its financial results for the year ended December 31, 2018. Over the course of 2018, the Company generated $12.6 million of cash from operations, with cash balance increasing to $12.7 million at year-end.

Following the announcement, Joseph Dowling, CEO of CV Sciences, said, "we finished 2018 with strong sales momentum and enter 2019 well positioned to capitalize on the rapidly growing consumer awareness and broad-based demand for hemp CBD products. We generated 133% revenue growth during 2018 and expanded the availability of the PlusCBDâ„¢ brand to over 2,200 stores nationwide. we are positioning our company to capitalize on this incremental growth opportunity with enhancements to our leadership team and business systems, and are in the planning process for expanded production and fulfillment capabilities to support rising demand."